CoChat

Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance

Open access
Liu, Zhongle, Myers, Lawrence C. · 2017 · Antimicrobial Agents and Chemotherapy

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 45 of the 82 sources its claims cite were checked for support.

Abstract

The Swi/Snf chromatin remodeling complex is a key coactivator for Mrr1 and is required to maintain basal and induced open chromatin and Mrr1 occupancy at the MDR1 promoter.

Overview

CoChat Summary

TL;DR

In *Candida albicans*, hyperactive Mrr1 requires Swi/Snf chromatin remodeling and Mediator tail module function for *MDR1* induction and fluconazole resistance, while the Mediator Cdk8/Ssn3 module acts negatively. Deleting *snf2* strongly lowers MRR1GOF fluconazole MIC and *MDR1* expression, and deleting *ssn3* suppresses these *snf2* defects and can further increase MIC.

Key findings

  • Deletion of *snf2* reduced fluconazole MIC in three MRR1GOF strains (Q350L, P683S, N803D) from 6–8 μg/ml to 0.75–1.5 μg/ml, whereas TAC1GOF strains showed only minor MIC decreases.
  • *med3* deletion reduced MRR1GOF fluconazole MIC but to a much lesser degree than *snf2* deletion; *ssn3* deletion increased MIC in MRR1GOF strains (e.g., Q350L 12 μg/ml; N803D 24 μg/ml), and *ssn3 snf2* double mutants showed even higher MICs (Q350L 24–32 μg/ml; N803D 48–64 μg/ml).
  • ChIP showed Snf2 occupancy at the *MDR1* promoter decreased almost 10-fold in an *mrr1* null strain, Mrr1 occupancy was dramatically reduced in an *snf2* null strain, and *ssn3* deletion increased Mrr1 occupancy and histone displacement at *MDR1* and *IFD6* under inducing conditions.
  • *snf2* deletion largely abrogated benomyl- and MRR1GOF-induced *MDR1*, *IFD6*, and *IFD1* expression; *ssn3* deletion suppressed the *snf2*-dependent decreases in gene expression, histone displacement, and fluconazole MIC.

Methods

  • *C. albicans* strains included MRR1GOF mutants (Q350L, P683S, N803D), TAC1GOF mutants, and deletions of *snf2*, *med3*, *ssn3*, *mdr1*, *mrr1*, plus an *ssn3* kinase-dead (*ssn3D325A*) mutant; cells were grown in YPD at 30°C and treated with benomyl, H₂O₂, or fluconazole.
  • Fluconazole MIC was measured by Etest at 30°C on YPD plates with 36–48 h incubation; gene expression was measured by RT-qPCR for *MDR1*, *IFD6*, *IFD1*, and *MRR1* with *ACT1* as internal reference.
  • ChIP was used for Mrr1, Snf2, Med17, Ssn3, and histone H3/H4 occupancy; data were analyzed as relative recovery of input, relative nucleosome density normalized to an *ADE2* +1 nucleosome amplicon, and histone displacement index, with t tests and P > 0.05 judged not significant.

Limitations

  • Stated by the authors: the origin of MDR1-independent resistance mechanisms in these strains remains incomplete; it is unclear how Swi/Snf remodeling activity is potentiated during induction; the functional significance of the Ssn3/Med3-dependent Mrr1 mobility shift is unclear; and whether cofactor dependence differences arise from transcription factor sequence, promoter chromatin structure, or both is an open question.
  • Stated by the authors: the role of additional Mrr1 target genes such as *IFD1* and *IFD6* in fluconazole resistance was not individually tested, and the precise mechanism by which Ssn3 kinase activity represses Mrr1 target promoters is unclear.
  • Evident from the text: the study uses laboratory *C. albicans* strains and defined GOF alleles rather than clinical isolates, and the main assays are in vitro (YPD, benomyl/H₂O₂/fluconazole, Etest, RT-qPCR, ChIP) rather than infection models; several strain/condition combinations in Table 1 are marked “—, not determined.”

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/aac.01344-17

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

28 Valid · 2 Not valid · 8 Not checked · 151 Own results and interpretations

129 more claims · 8 with their cited sources checked

Create a free account to see all 189 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 52

Metadata

Authors
Liu, Z., & Myers, L. C.
Affiliations
Dartmouth College (US)
Venue
Antimicrobial Agents and Chemotherapy
Published
2017-11
Volume
61
Issue
11
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2749779981
Cited by
51
References
58
Citations by year
2026: 7 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 1
FWCI
2.32
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
HHS | National Institutes of Health (5R21AI113390)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
Candida albicans, fluconazole resistance, MRR1, MDR1, SWI/SNF complex, Mediator complex, chromatin remodeling, transcriptional coactivation, drug efflux pumps, azole resistance, zinc cluster transcription factors, SnF2, histone displacement, open chromatin, transcriptional regulation
MeSH terms
Antifungal Agents, Candida albicans, Fungal Proteins, Histones, Mutation, Nucleosomes, Promoter Regions, Genetic, Fluconazole, Gene Expression Regulation, Fungal, ATP Binding Cassette Transporter, Subfamily B, Member 1, Drug Resistance, Fungal, Mediator Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.